Klaus Eistetter

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
NYCOMED GERMANY HOLDING GMBH
1
2013
BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH
2
1
2
1
1
1977
1978
1980
1981
1982
MediGene AG Gesellschaft fur Molekularbiologische Kardiologie und Onkologie
1
1987
Regie Nationale des Usines Renault
1
1982
HORST P.O. WOLF
1
1987
NYCOMED GMBH
1
1
2004
2006
TAKEDA GMBH
1
1
1
1
1
1998
2004
2006
2010
2013
ATLANTA PHARMA AG
1
2004
KLAUS EISTETTER BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH
1
1987
WOLF, HORST P.O.
1
1981
ASTRAZENECA AB
1
1
1
1
2
3
3
1999
2002
2003
2004
2011
2013
2015
FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
2
2006

Inventor Addresses

AddressDuration
Constance, DEApr 15, 80 - Jul 25, 17
Konstanz, DEFeb 07, 84 - Oct 15, 15

Technology Profile

Technology Matters
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 24
A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 3

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
97136822017Device for dosing and dry nebulization12
94685982016Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient0
2015/0290,1782015Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient1
2015/0290,1792015Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient1
2015/0290,1802015Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient1

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.